Psychopharmacology

, Volume 181, Issue 1, pp 90–100 | Cite as

Role of withdrawal in reinstatement of morphine-conditioned place preference

  • Lin Lu
  • Hai Chen
  • Wenjuan Su
  • Xin Ge
  • Wen Yue
  • Fen Su
  • Lan Ma
Original Investigation

Abstract

Rationale

Relapse is a major characteristic of drug addiction and the primary problem in treating drug abuse. Based on the negative reinforcement view of addiction, in which the motivation to take drugs is thought to result from the desire to avoid the aversive effect of drug withdrawal, it has been theorized that withdrawal symptoms play a major role in the maintenance of and relapse to drug taking. However, the role of withdrawal in relapse has not yet been systemically investigated in the reinstatement model.

Objectives

Using a conditioned place preference (CPP) paradigm, we examined the role of different morphine withdrawal states (spontaneous withdrawal, naloxone-precipitated withdrawal, and conditioned withdrawal) in relapse to drug seeking.

Methods

Rats alternately received morphine (10 mg/kg, s.c.) and saline for 8 days to acquire the CPP. The morphine CPP disappeared after a 2-week extinction phase of saline-paired training. Rats were then chronically administered morphine to induce physical dependence. The different withdrawal states were induced and their roles in the reinstatement of extinguished CPP were assessed. During conditioned withdrawal, trunk blood samples were taken and the corticosterone level was measured by radioimmunoassay. To examine the role of corticotropin-releasing factor (CRF) receptor antagonist on conditioned-withdrawal-induced reinstatement of CPP, different doses of α-helical CRF (0.1 and 1 μg, i.c.v.) were administered 30 min prior to the CPP testing.

Results

The results show that morphine spontaneous withdrawal and naloxone-precipitated morphine withdrawal were ineffective in reinstating morphine CPP. However, the withdrawal cues significantly elicited the reinstatement of CPP and increased corticosterone level. Moreover, pretreatment with the CRF receptor antagonist α-helical CRF (1 μg, i.c.v.) significantly attenuated the effects of withdrawal cues on reinstatement of CPP and corticosterone levels.

Conclusion

These findings demonstrate that the cues associated with previous drug withdrawal play a major role in drug relapse and that activation of the CRF receptor is involved in conditioned-withdrawal-induced reinstatement. The present study suggests that CRF receptor antagonists might be of value in the treatment and prevention of relapse to drug seeking after long-term abstinence.

Keywords

Conditioned place preference Drug-seeking Withdrawal Cue conditioning Morphine Relapse 

Notes

Acknowledgements

This work was supported in part by grants from the National Natural Science Foundation of China (30000050 to Lin Lu and 30230130 to Lan Ma). We thank Yavin Shaham for helpful comments and Emily Wentzell for editorial assistance.

References

  1. Aston-Jones G, Harris GC (2004) Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47 Suppl 1:167–179CrossRefPubMedGoogle Scholar
  2. Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31–43CrossRefPubMedGoogle Scholar
  3. Bardo MT, Rowlett JK, Harris MJ (1995) Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19:39–51CrossRefPubMedGoogle Scholar
  4. Basso AM, Spina M, Rivier J, Vale W, Koob GF (1999) Corticotropin-releasing factor antagonist attenuates the “anxiogenic-like” effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) 145:21–30CrossRefGoogle Scholar
  5. Childress AR, Mclellan TA, O’Brien CP (1986) Role of conditioning factors in the development of drug dependence. Psychiatr Clin North Am 9:413–425PubMedGoogle Scholar
  6. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O’Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11–18PubMedGoogle Scholar
  7. de Wit H, Stewart J (1983) Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology 79:29–31PubMedCrossRefGoogle Scholar
  8. Fukunaga Y, Nishida S, Inoue N, Miyamoto M, Kishioka S, Yamamoto H (1998) Time course of morphine withdrawal and preproenkephalin gene expression in the periaqueductal gray of rats. Brain Res Mol Brain Res 55:221–231CrossRefPubMedGoogle Scholar
  9. Gawin FH, Ellinwood EH Jr (1988) Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med 318:1173–1182PubMedCrossRefGoogle Scholar
  10. Goeders NE (1997) A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22:237–259PubMedCrossRefGoogle Scholar
  11. Goeders NE (2002) Stress and cocaine addiction. J Pharmacol Exp Ther 301:785–789CrossRefPubMedGoogle Scholar
  12. Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, Phillips RL, Kimes AS, Margolin A (1996) Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A 93:12040–12045CrossRefPubMedGoogle Scholar
  13. Hand TH, Koob GF, Stinus L, Le Moal M (1988) Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res 474:364–368CrossRefPubMedGoogle Scholar
  14. Harris GC, Aston-Jones G (2003) Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing. Neuropsychopharmacology 28:865–871PubMedCrossRefGoogle Scholar
  15. Hoffman DC (1989) The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res Bull 23:373–387CrossRefPubMedGoogle Scholar
  16. Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A (2001) The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci 4:943–947CrossRefPubMedGoogle Scholar
  17. Iredale PA, Alvaro JD, Lee Y, Terwilliger R, Chen YL, Duman RS (2000) Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. J Neurochem 74:199–208CrossRefPubMedGoogle Scholar
  18. Jaffe JH, Cascell NG, Kumor KM, Sherer MA (1989) Cocaine-induced cocaine craving. Psychopharmacology 97:59–64CrossRefPubMedGoogle Scholar
  19. Koob GF (1999) Stress, corticotropin-releasing factor, and drug addiction. Ann N Y Acad Sci 897:27–45PubMedCrossRefGoogle Scholar
  20. Koob GF, Bloom FE (1985) Corticotropin-releasing factor and behavior. Fed Proc 44:259–263PubMedGoogle Scholar
  21. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52–58CrossRefPubMedGoogle Scholar
  22. Koob GF, Stinus L, Le Moal M, Bloom FE (1989) Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev 13:135–140PubMedCrossRefGoogle Scholar
  23. Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward systems. Drug Alcohol Depend 51:23–47CrossRefPubMedGoogle Scholar
  24. Leith NJ, Barrett RJ (1976) Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacology 46:19–25CrossRefGoogle Scholar
  25. Lu L, Ceng X, Huang M (2000a) Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats. NeuroReport 11:2373–2378PubMedCrossRefGoogle Scholar
  26. Lu L, Liu D, Ceng X, Ma L (2000b) Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur J Neurosci 12:4398–4404PubMedCrossRefGoogle Scholar
  27. Lu L, Zeng S, Liu D, Ceng X (2000c) Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci Lett 291:191–195CrossRefPubMedGoogle Scholar
  28. Lu L, Xu NJ, Ge X, Yue W, Su WJ, Pei G, Ma L (2002) Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization. Psychopharmacology 159:125–132CrossRefPubMedGoogle Scholar
  29. Lu L, Grimm JW, Shaham Y, Hope BT (2003a) Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem 85:1604–1613CrossRefPubMedGoogle Scholar
  30. Lu L, Shepard JD, Scott Hall F, Shaham Y (2003b) Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev 27:457–491CrossRefPubMedGoogle Scholar
  31. Maldonado R, Negus S, Koob GF (1992) Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology 31:1231–1241CrossRefPubMedGoogle Scholar
  32. Menzaghi F, Rassnick S, Heinrichs S, Baldwin H, Merlo Pich M, Weiss F, Koob GF (1994) The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann N Y Acad Sci 739:176–184PubMedCrossRefGoogle Scholar
  33. Miller D, Dougherty J, Wikler A (1979) Interoceptive conditioning through repeated suppression of morphine abstinence. II. Relapse testing. Pavlovian J Biol Sci 14:170–176Google Scholar
  34. Mueller D, Stewart J (2000) Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res 115:39–47CrossRefPubMedGoogle Scholar
  35. Mueller D, Perdikaris D, Stewart J (2002) Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res 136:389–397CrossRefPubMedGoogle Scholar
  36. Myrick H, Brady KT, Malcolm R (2001) New developments in the pharmacotherapy of alcohol dependence. Am J Addict 10:3–15PubMedGoogle Scholar
  37. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119–128CrossRefPubMedGoogle Scholar
  38. O’Brien CP (1997) A range of research-based pharmacotherapies for addiction. Science 278:66–70PubMedCrossRefGoogle Scholar
  39. O’Brien CP, Childress AR, Mclellan TA, Ehrman R (1992) Classical conditioning in drug dependent humans. Ann N Y Acad Sci 654:400–415PubMedCrossRefGoogle Scholar
  40. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San Diego, CAGoogle Scholar
  41. Piazza PV, Le Moal M (1996) Pathophysiological basis of vulnerability to drug abuse: interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359–378CrossRefPubMedGoogle Scholar
  42. Piazza PV, Le Moal M (1997) Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Rev 25:359–372CrossRefPubMedGoogle Scholar
  43. Powell J, Bradley B, Gray J (1992) Classical conditioning and cognitive determinants of subjective craving for opiates: an investigation of their relative contributions. Br J Addict 87:1133–1144PubMedCrossRefGoogle Scholar
  44. Rasmussen K, Kendrick WT, Kogan JH, Aghajanian GK (1996) A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology 15:497–505CrossRefPubMedGoogle Scholar
  45. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247–291CrossRefPubMedGoogle Scholar
  46. Ruiz F, Fournie-Zaluski MC, Roques BP, Maldonado R (1996) Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism. Br J Pharmacol 119:174–182PubMedGoogle Scholar
  47. Sanchez CJ, Sorg BA (2001) Conditioned fear stimuli reinstate cocaine-induced conditioned place preference. Brain Res 908:86–92CrossRefPubMedGoogle Scholar
  48. Sanchez CJ, Bailie TM, Wu W, Li N, Sorg BA (2003) Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 119:497–505CrossRefPubMedGoogle Scholar
  49. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G (1995) Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats. Brain Res 657:89–97CrossRefGoogle Scholar
  50. Sarnyai Z, Shaham Y, Heinrichs SC (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53:209–244PubMedGoogle Scholar
  51. Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD (1991) Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 148:1712–1716PubMedGoogle Scholar
  52. Schulteis G, Ahmed SH, Morse AC, Koob GF, Everitt BJ (2000) Conditioning and opiate withdrawal. Nature 405:1013–1014CrossRefPubMedGoogle Scholar
  53. See RE (2002) Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 71:517–529CrossRefPubMedGoogle Scholar
  54. Shaham Y, Stewart J (1995) Stress reinstates heroin self-administration behavior in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119:334–341PubMedCrossRefGoogle Scholar
  55. Shaham Y, Rajabi H, Stewart J (1996) Relapse to heroin-seeking under opioid maintenance: the effects of opioid withdrawal, heroin priming and stress. J Neurosci 16:1957–1963PubMedGoogle Scholar
  56. Shaham Y, Erb S, Stewart J (2000) Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 33:13–33CrossRefPubMedGoogle Scholar
  57. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168:3–20CrossRefPubMedGoogle Scholar
  58. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1–42CrossRefPubMedGoogle Scholar
  59. Sinha R, Fuse T, Aubin LR, O’Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology 152:140–148CrossRefPubMedGoogle Scholar
  60. Solomon R, Corbit J (1974) An opponent process theory of motivation. I. Temporal dynamics of affect. Psychol Rev 81:119–145PubMedCrossRefGoogle Scholar
  61. Stewart J (2000) Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 25:125–136PubMedGoogle Scholar
  62. Stewart J, de Wit H, Eikelboom R (1984) Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 91:251–268CrossRefPubMedGoogle Scholar
  63. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613–672CrossRefPubMedGoogle Scholar
  64. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide the stimulates secretion of corticotropin and beta-endorphin. Science 213:1394–1397PubMedCrossRefGoogle Scholar
  65. Wang X, Cen X, Lu L (2001) Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol 432:153–161CrossRefPubMedGoogle Scholar
  66. Wang B, Luo F, Ge XC, Fu AH, Han JS (2002) Effects of lesions of various brain areas on drug priming or footshock-induced reactivation of extinguished conditioned place preference. Brain Res 950:1–9CrossRefPubMedGoogle Scholar
  67. Wikler A (1948) Recent progress in research on the neurophysiological basis of morphine addiction. Am J Psychiatry 105:329–338PubMedGoogle Scholar
  68. Wikler A, Pescor FT (1967) Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and “relapse” in morphine addicted rats. Psychopharmacologia 20:255–284CrossRefGoogle Scholar
  69. Wise RA (1988) The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 97:118–132CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Lin Lu
    • 1
    • 2
  • Hai Chen
    • 1
  • Wenjuan Su
    • 1
  • Xin Ge
    • 1
  • Wen Yue
    • 1
  • Fen Su
    • 1
  • Lan Ma
    • 1
  1. 1.National Laboratory of Medical Neurobiology and Pharmacology Research CenterFudan UniversityShanghaiChina
  2. 2.Behavioral Neuroscience BranchIRP/NIDA/NIHBaltimoreUSA

Personalised recommendations